Examination of relation between infliximab blood concentration and the frequency of second failure and effect maintenance after the infliximab secession.
Not Applicable
- Conditions
- psoriasis
- Registration Number
- JPRN-UMIN000012289
- Lead Sponsor
- Osaka city university medical school department of dermatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
It is a patient with the infliximab treatment experience in the past. The patient who judged that a study person in charge or an enforcement partaker was inappropriate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method achievement rate of PASI75
- Secondary Outcome Measures
Name Time Method